TNSN06114A1 - PHARMACEUTICAL FORMULATIONS, METHODS AND ADMINISTRATION DIAGRAMS FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES - Google Patents

PHARMACEUTICAL FORMULATIONS, METHODS AND ADMINISTRATION DIAGRAMS FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES

Info

Publication number
TNSN06114A1
TNSN06114A1 TNP2006000114A TNSN06114A TNSN06114A1 TN SN06114 A1 TNSN06114 A1 TN SN06114A1 TN P2006000114 A TNP2006000114 A TN P2006000114A TN SN06114 A TNSN06114 A TN SN06114A TN SN06114 A1 TNSN06114 A1 TN SN06114A1
Authority
TN
Tunisia
Prior art keywords
des
formulations
administration
diagrams
prevention
Prior art date
Application number
TNP2006000114A
Other languages
French (fr)
Inventor
Wendi V Rodrigueza
Daniel Hartman
Jan Johansson
Narendra D Lalwani
Charles L Bisgaier
Original Assignee
Esperion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/034800 external-priority patent/WO2005041866A2/en
Application filed by Esperion Therapeutics Inc filed Critical Esperion Therapeutics Inc
Publication of TNSN06114A1 publication Critical patent/TNSN06114A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Effet aigu d'une dose unique de ETC-216 sur le taux sérique de cholestérol non estérifié-HDL chez des sujets humains masculins normaux (ETC-216-001) La présente invention propose des méthodes et formulations pour le traitement et la prévention de syndromes coronariens aigus. Les méthodes de la présente invention fournissent des doses sures et efficaces d'un complexe apolipoprotéine A-I Milano : phospholipide pour réduire et stabiliser la plaque athérosclérotique. Des formulations pharmaceutiques des complexes Apo-A-I Milano : phospholipide sont également proposées.
TNP2006000114A 2003-10-20 2006-04-20 PHARMACEUTICAL FORMULATIONS, METHODS AND ADMINISTRATION DIAGRAMS FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES TNSN06114A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51311603P 2003-10-20 2003-10-20
PCT/US2004/034800 WO2005041866A2 (en) 2003-10-20 2004-10-19 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes

Publications (1)

Publication Number Publication Date
TNSN06114A1 true TNSN06114A1 (en) 2007-11-15

Family

ID=37444404

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000114A TNSN06114A1 (en) 2003-10-20 2006-04-20 PHARMACEUTICAL FORMULATIONS, METHODS AND ADMINISTRATION DIAGRAMS FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES

Country Status (5)

Country Link
CN (1) CN1870894B (en)
AP (1) AP2006003578A0 (en)
IS (1) IS8356A (en)
TN (1) TNSN06114A1 (en)
ZA (1) ZA200602248B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014006589A (en) * 2011-12-21 2014-10-17 Csl Ltd Dosage regime for apolipoprotein formulations.
CN105483076B (en) 2015-12-23 2019-01-25 中国科学院生物物理研究所 A kind of preparation method and applications of fat-body

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625435D0 (en) * 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
IT1229996B (en) * 1989-04-20 1991-09-20 Cesare Sirtori EXPRESSION OF APOLIPOPROTEIN AI AND APOLIPOPROTEIN AI-MILAN IN YEAST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE APOLIPOPROTEINS.
SE9603304D0 (en) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
JP2005504085A (en) * 2001-09-28 2005-02-10 エスペリオン セラピューティクス，インコーポレイテッド Prevention and treatment of restenosis by local administration of drugs

Also Published As

Publication number Publication date
CN1870894B (en) 2011-08-10
IS8356A (en) 2006-03-16
ZA200602248B (en) 2007-09-26
CN1870894A (en) 2006-11-29
AP2006003578A0 (en) 2006-04-30

Similar Documents

Publication Publication Date Title
MA28102A1 (en) PHARMACEUTICAL FORMULATIONS, METHODS AND ADMINISTRATION DIAGRAMS FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES
TNSN06439A1 (en) DERIVATIVES OF 2-CARBAMIDE -4-PHENYLTHIAZOLE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ITRM990338A0 (en) DIETARY OR PHARMACEUTICAL COMPOSITION USEFUL FOR THE PREVENTION OR TREATMENT OF HYPEROXALURIA.
NO20025601D0 (en) Arylmethylamine derivatives for use as tryptase inhibitors
EA200100872A1 (en) COMPOSITION VALDEKOKSIBA
HUP0301281A2 (en) New pharmaceutical composition
ATE339406T1 (en) CHINAZOLINE COMPOUNDS AS REMEDIES
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
DE60323765D1 (en) INHIBITORS OF 17-BETA-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 3 FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
GB0002336D0 (en) Medicaments
BR0002577A (en) Oral suspensions of trovafloxacin
CY1105545T1 (en) STATIN THERAPY TO ENHANCE THE PRESERVATION OF MENTAL FUNCTION
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
ATE319473T1 (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
PL1656131T3 (en) Use of betaine for treating intermittent claudication
TNSN06114A1 (en) PHARMACEUTICAL FORMULATIONS, METHODS AND ADMINISTRATION DIAGRAMS FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES
EE200100689A (en) Use of IL6RIL6 Chimera for the preparation of a medicament for the treatment of neurological diseases, and pharmaceutical composition
SE0004827D0 (en) Therapeutic compounds
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
SE0203817D0 (en) New composition
AR030660A1 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ILLNESS ASSOCIATED WITH AN EXCESS OF IL-12 PRODUCTION
ATE337790T1 (en) USE OF CORTISOL SEQUESTRING AGENTS TO TREAT HYPERCORTISOLAEMIA-RELATED DISEASES
DE60226126D1 (en) USE OF GAMMA-GT INHIBITORS FOR THE TREATMENT OF CHRONIC DEGENERATIVE DISEASES
PL369845A1 (en) Use of 4-oxobutanoic acid derivatives in the treatment of inflammation